Wendie A. Berg, MD, PhD, FACR, FSBI is Professor of Radiology at University of Pittsburgh School of Medicine, was PI of ACRIN 6666, Screening Breast Ultrasound (US) and MRI. Dr. Berg has led and analyzed prospective trials evaluating elastography, positron emission mammography, MRI, and molecular breast imaging. She is currently leading several screening trials comparing tomosynthesis and contrast-enhanced mammography. Dr. Berg is Chief Scientific Advisor to www.DenseBreast-info.org, served on committees for the BI-RADS 3rd ,4th, and 5th editions for mammography and 1st and 2nd editions for ultrasound. She has over 125 peer-reviewed publications, including recently published results on the DBTUST trial of screening ultrasound after tomosynthesis, and has been co-lead editor/author of 3 editions of Diagnostic Imaging: Breast and the associated content in StatDx.
Apr 10, 2023 16:13 pm UTC| Health
The U.S. Food and Drug Administration finalized a regulation in early March 2023 that updates mammography reporting requirements. The new regulation goes into effect on Sept. 10, 2024, and will require that all women...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Why Germany ditched nuclear before coal – and why it won’t go back
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight